跳至主要内容
临床试验/JPRN-UMIN000031979
JPRN-UMIN000031979已完成未知

Proactive management with topical corticosteroids ointment in pediatric atopic dermatitis : Superiority to rank-down therapy - Proactive management with topical corticosteroids ointment in pediatric atopic dermatitis : Superiority to rank-down therapy (Anticipate study)

Jichi Medical University School of Medicine0 个研究点目标入组 90 人开始时间: 2018年3月29日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
6years-old 至 15years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients meeting any of the following criteria are not to be enrolled in the study. (1) Patients with skin infections caused by bacteria, fungi, spirochetes or viruses and patients with ectoparasitic skin diseases (scabies, pubic lice, etc.). (2)History of hypersensitivity to any components of the topical steroid and/or moisturizer to be used (3) Patients with ulcers (except for Bechet's disease) and patients with deep burns or frostbite of second degree or higher. (4) Patients complicated with an active infection in the area the study drug is to be applied. (5) Patients complicated with Kaposi's varicelliform eruption, scabies, molluscum contagious, psoriasis, disorders (Netherton syndrome, etc.) presenting with ichthyosiform erythroderma, collagen disease (SLE and dermatomyositis), and skin disorder on the area study drug is to be applied to, which can affect evaluation. (6) Patients who used the following drug within 28 days prior to Visit 1 (at the time of informed consent) > Systemic adrenocortical steroid (oral, injectable, suppository, and inhaled) > Topical steroid (strongest) > Systemic immunosuppressant > Live vaccine (7) Patients who received phototherapy (UVB, Narrow-band UVB, PUVA , etc.) within 28 days prior to Visit 1 (at the time of informed consent) (8) Patients who participated in another clinical trial (including clinical trial of medical device) or clinical research involving intervention within 12 weeks prior to Visit 1 (at the time of informed consent) (9) Patients determined by the investigator to be unsuitable for the study.

研究者

发起方
Jichi Medical University School of Medicine

相似试验